Scarica l'app Stockscreener
1.09
6.03%
-0.07
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CTSO Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.16
Aprire:
$1.14
Volume 24 ore:
2,906
Relative Volume:
0.03
Capitalizzazione di mercato:
$64.38M
Reddito:
$33.79M
Utile/perdita netta:
$-18.67M
Rapporto P/E:
-3.043
EPS:
-0.3582
Flusso di cassa netto:
$-19.17M
1 W Prestazione:
+5.83%
1M Prestazione:
+4.81%
6M Prestazione:
+4.81%
1 anno Prestazione:
+34.73%
Intervallo 1D:
$1.1017
$1.15
Intervallo di 1 settimana:
$1.01
$1.16
Portata 52W:
$0.70
$1.61
Cytosorbents Corp Stock (CTSO) Company Profile
Nome
Cytosorbents Corp
Settore
Industria
Telefono
973-329-8885
Indirizzo
305 COLLEGE ROAD EAST, PRINCETON, NJ
Confronta CTSO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CTSO
Cytosorbents Corp
|
1.13 | 64.38M | 33.79M | -18.67M | -19.17M | -0.3582 |
|
ABT
Abbott Laboratories
|
127.79 | 227.16B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
101.18 | 140.69B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
360.64 | 132.32B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
83.67 | 105.94B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
75.24 | 41.90B | 5.72B | 4.17B | 259.90M | 6.97 |
Cytosorbents Corp Stock (CTSO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-09-07 | Iniziato | B. Riley Securities | Buy |
| 2021-10-14 | Ripresa | B. Riley Securities | Buy |
| 2020-09-17 | Iniziato | Jefferies | Buy |
| 2020-09-01 | Iniziato | SVB Leerink | Outperform |
| 2017-08-08 | Reiterato | Maxim Group | Buy |
| 2016-10-26 | Iniziato | Aegis Capital | Buy |
| 2016-05-24 | Iniziato | Maxim Group | Buy |
| 2015-10-29 | Aggiornamento | WBB Securities | Speculative Buy → Buy |
| 2015-05-12 | Reiterato | MLV & Co | Buy |
| 2015-04-01 | Reiterato | MLV & Co | Buy |
| 2015-03-05 | Iniziato | MLV & Co | Buy |
| 2015-02-25 | Iniziato | WBB Securities | Speculative Buy |
| 2015-01-27 | Reiterato | H.C. Wainwright | Buy |
Mostra tutto
Cytosorbents Corp Borsa (CTSO) Ultime notizie
CytoSorbents secures $1.7M via NJ tax credit transfer - Investing.com
CytoSorbents Lands $1.7M Strategic Funding: New DrugSorb Product Launch and Manufacturing Expansion Ahead - Stock Titan
Cytosorbents (NASDAQ:CTSO) Now Covered by StockNews.com - Defense World
CytoSorbents Appoints Melanie Grossman, CPA as Vice President and Corporate Controller - PR Newswire
Cytosorbents Appoints Thomas Shannon As Vice President Of Marketing For North America - marketscreener.com
Strategic Hire: Medtronic $450M Portfolio Leader Joins CytoSorbents to Drive Breakthrough Device Launch - Stock Titan
Raymond James Financial Inc. Takes Position in Cytosorbents Co. (NASDAQ:CTSO) - Defense World
Cytosorbents (NASDAQ:CTSO) Now Covered by Analysts at StockNews.com - Defense World
Analysts Offer Predictions for Cytosorbents Q1 Earnings - Defense World
Brokers Offer Predictions for Cytosorbents Q1 Earnings - Defense World
Analysts Set Expectations for Cytosorbents FY2028 Earnings - Defense World
Cytosorbents (NASDAQ:CTSO) Earns “Neutral” Rating from HC Wainwright - Defense World
CytoSorbents extends Series B Warrants expiration to June 10 - Investing.com
Cytosorbents CorpExtends Expiration Date Of Series B Right Warrants To June 10, 2025SEC Filing - MarketScreener
CytoSorbents extends Series B Warrants expiration to June 10 By Investing.com - Investing.com UK
CytoSorbents Gives Investors More Time: Series B Warrants Now Extended to June 2025 - Stock Titan
Cytosorbents (NASDAQ:CTSO) Coverage Initiated at StockNews.com - Defense World
Cytosorbents (NASDAQ:CTSO) Given Buy Rating at D. Boral Capital - Defense World
Cytosorbents Corp Reports Strong Growth Amid Challenges - TipRanks
CytoSorbents Corp Q4 2024 Earnings: EPS Misses at -$0.06, Revenue Falls Short at $9.2 Million - GuruFocus
The Analyst Verdict: CytoSorbents In The Eyes Of 4 Experts - Benzinga
Cytosorbents Corporation (NASDAQ:CTSO) Q4 2024 Earnings Call Transcript - Insider Monkey
CytoSorbents: Q4 Earnings Snapshot - CT Insider
CytoSorbents Corp (CTSO) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
CytoSorbents Corp (CTSO) Q4 2024 Earnings Call Highlights: Stron - GuruFocus
CytoSorbents Corporation Reports Strong 2024 Performance - TipRanks
Earnings call transcript: Cytosorbents Crp Q4 2024 beats EPS forecast By Investing.com - Investing.com Canada
CTSOCytosorbents Corp Latest Stock News & Market Updates - Stock Titan
Cytosorbents Corp reports results for the quarter ended December 31Earnings Summary - TradingView
Cytosorbents Corp SEC 10-K Report - TradingView
CytoSorbents Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights - TradingView
CYTOSORBENTS Earnings Results: $CTSO Reports Quarterly Earnings - Nasdaq
Cytosorbents (CTSO) Expected to Post Improved Earnings and Reven - GuruFocus
Insights into CytoSorbents's Upcoming Earnings - Benzinga
CytoSorbents Corp (CTSO) Q4 2024 Earnings Report Preview: What t - GuruFocus.com
Cytosorbents (CTSO) Expected to Announce Quarterly Earnings on Monday - Defense World
CytoSorbents Corp (CTSO) Reports Q4 Revenue Between $9.0M and $9 - GuruFocus
CytoSorbents Reschedules Earnings Release to March 31, 2025 to Allow Additional Time to Complete Annual Audit - Longview News-Journal
CytoSorbents Q4 Revenue Jumps 25% Despite Earnings DelayKey Metrics Released - StockTitan
Cytosorbents (NASDAQ:CTSO) Share Price Passes Above Two Hundred Day Moving Average – Here’s Why - Defense World
CytoSorbents Stock Price, Quotes and Forecasts | NASDAQ:CTSO - Benzinga
Cytosorbents (NASDAQ:CTSO) shareholders have endured a 78% loss from investing in the stock five years ago - Yahoo Finance
StockNews.com Initiates Coverage on Cytosorbents (NASDAQ:CTSO) - Defense World
CytoSorbents Corp. to Host Earnings Call - ACCESS Newswire
CytoSorbents Corp (CTSO) Q4 2024 Earnings Report Preview: What T - GuruFocus.com
CytoSorbents Corp (CTSO) Q4 2024 Earnings Report Preview: What To Expect - Yahoo Finance
Cytosorbents Corp Reaffirms Preliminary Financial Expectations For Q4 And FY 2024 -March 04, 2025 at 04:52 pm EST - Marketscreener.com
CytoSorbents delays earnings call after VP’s passing - Investing.com India
Cytosorbents Corp Azioni (CTSO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.99%
0.60%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):